|
Volumn 63, Issue 3, 1998, Pages 301-310
|
Ovarian cancer
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA FETOPROTEIN;
ALTRETAMINE;
ANDROGEN;
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CA 125 ANTIGEN;
CA 15-3 ANTIGEN;
CA 19-9 ANTIGEN;
CARBOPLATIN;
CARCINOEMBRYONIC ANTIGEN;
CHLORAMBUCIL;
CHORIONIC GONADOTROPIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DACTINOMYCIN;
DOCETAXEL;
DOXORUBICIN;
ESTROGEN;
ETOPOSIDE;
IFOSFAMIDE;
INHIBIN;
LACTATE DEHYDROGENASE;
METHOTREXATE;
PACLITAXEL;
SIALIC ACID;
TOPOTECAN;
TUMOR ANTIGEN;
UNINDEXED DRUG;
VINBLASTINE;
VINCRISTINE;
BLOOD TOXICITY;
CANCER ADJUVANT THERAPY;
CANCER PALLIATIVE THERAPY;
CANCER RECURRENCE;
CANCER SCREENING;
CANCER STAGING;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
DYSGERMINOMA;
FOLLOW UP;
GASTROINTESTINAL SYMPTOM;
GERM CELL TUMOR;
HUMAN;
HYSTERECTOMY;
IMAGING;
INTRAPERITONEAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
LAPAROTOMY;
OVARY CANCER;
PELVIS;
PHYSICAL EXAMINATION;
PRIORITY JOURNAL;
RADIOGRAPHY;
REVIEW;
RISK FACTOR;
SALPINGOOOPHORECTOMY;
SURGICAL APPROACH;
SURGICAL TECHNIQUE;
TRANSVAGINAL ECHOGRAPHY;
TUMOR SUPPRESSOR GENE;
YOLK SAC TUMOR;
|
EID: 0032241263
PISSN: 00207292
EISSN: None
Source Type: Journal
DOI: 10.1016/S0020-7292(98)90151-5 Document Type: Review |
Times cited : (3)
|
References (20)
|